Browse the corpus

REFERENCES DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, “Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, Department of Health and Human Services,” February 12, 2013;1-267. Available at file://www.aidsinfo.nih.gov DHHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, "Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States," July 31, 2012. Available at file://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf Molina JM, Andrade-Villanueva J, Echevarria J, et al, “Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study,” J Acquir Immune Defic Syndr , 2010, 53(3):323-32. [PubMed 20032785 ] Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, “Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection,” August 16, 2010. Available at file://www.aidsinfo.nih.gov Topic 9353 Version 51.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.3 - C21.34 Licensed to: Morehouse School of Medicine | Support Tag: [1104-118.195.65.244-FC54B750F8-S473950.14]